BACKGROUND: Aging and diabetes are major risk factors for poor wound healing and tissue regeneration that reflect an impaired ability to respond to ischemic insults. The authors explored the intrinsic neovascular potential of adipose-derived stromal cells in the setting of advanced age and in type 1 and type 2 diabetes. METHODS: Adipose-derived stromal cells isolated from young, aged, streptozotocin-induced, and db/db diabetic mice were exposed to normoxia and hypoxia in vitro. Vascular endothelial growth factor (VEGF) expression, proliferation, and tubulization were measured. Conditioned media harvested from adipose-derived stromal cell cultures were assessed for their ability to stimulate human umbilical vein endothelial cell proliferation (n = 3 and n = 3). RESULTS: Young adipose-derived stromal cells demonstrated significantly higher levels of VEGF production, proliferation, and tubulogenesis than those derived from aged, streptozotocin-induced, and db/db mice in both normoxia and hypoxia. Although aged and diabetic adipose-derived stromal cells retained the ability to up-regulate VEGF secretion, proliferation, and tubulogenesis in response to hypoxia, the response was blunted compared with young controls. Conditioned media derived from these cells cultured in normoxia in vitro also had a significantly greater ability to increase human umbilical vein endothelial cell proliferation compared with media harvested from aged, streptozotocin-induced, and db/db adipose-derived stromal cells. This effect was magnified in conditioned media harvested from hypoxic adipose-derived stromal cell cultures. CONCLUSIONS: This study demonstrates that aging and type 1 and type 2 diabetes impair intrinsic adipose-derived stromal cell function; however, these cells may still be a suitable source of angiogenic cells that can potentially improve neovascularization of ischemic tissues.
BACKGROUND: Aging and diabetes are major risk factors for poor wound healing and tissue regeneration that reflect an impaired ability to respond to ischemic insults. The authors explored the intrinsic neovascular potential of adipose-derived stromal cells in the setting of advanced age and in type 1 and type 2 diabetes. METHODS:Adipose-derived stromal cells isolated from young, aged, streptozotocin-induced, and db/dbdiabeticmice were exposed to normoxia and hypoxia in vitro. Vascular endothelial growth factor (VEGF) expression, proliferation, and tubulization were measured. Conditioned media harvested from adipose-derived stromal cell cultures were assessed for their ability to stimulate human umbilical vein endothelial cell proliferation (n = 3 and n = 3). RESULTS: Young adipose-derived stromal cells demonstrated significantly higher levels of VEGF production, proliferation, and tubulogenesis than those derived from aged, streptozotocin-induced, and db/dbmice in both normoxia and hypoxia. Although aged and diabeticadipose-derived stromal cells retained the ability to up-regulate VEGF secretion, proliferation, and tubulogenesis in response to hypoxia, the response was blunted compared with young controls. Conditioned media derived from these cells cultured in normoxia in vitro also had a significantly greater ability to increase human umbilical vein endothelial cell proliferation compared with media harvested from aged, streptozotocin-induced, and db/dbadipose-derived stromal cells. This effect was magnified in conditioned media harvested from hypoxic adipose-derived stromal cell cultures. CONCLUSIONS: This study demonstrates that aging and type 1 and type 2 diabetes impair intrinsic adipose-derived stromal cell function; however, these cells may still be a suitable source of angiogenic cells that can potentially improve neovascularization of ischemic tissues.
Authors: Mi Hyang Moon; Sun Young Kim; Yeon Jeong Kim; Su Jin Kim; Jae Bong Lee; Yong Chan Bae; Sang Min Sung; Jin Sup Jung Journal: Cell Physiol Biochem Date: 2006-06-20
Authors: Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner Journal: Circulation Date: 2002-11-26 Impact factor: 29.690
Authors: M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak Journal: Science Date: 1999-04-02 Impact factor: 47.728
Authors: David Burmeister; Tamer Aboushwareb; Josh Tan; Kerry Link; Karl-Erik Andersson; George Christ Journal: Tissue Eng Part A Date: 2010-08 Impact factor: 3.845
Authors: Gregory M Cooper; Emily L Durham; James J Cray; Michael R Bykowski; Gary E DeCesare; Melissa A Smalley; Mark P Mooney; Phil G Campbell; Joseph E Losee Journal: Plast Reconstr Surg Date: 2011-01 Impact factor: 4.730
Authors: Melanie Rodrigues; Victor W Wong; Robert C Rennert; Christopher R Davis; Michael T Longaker; Geoffrey C Gurtner Journal: Am J Pathol Date: 2015-06-13 Impact factor: 4.307
Authors: Natalie N Chung; Ryan C Ransom; Charles P Blackshear; Dre M Irizarry; Derek Yen; Arash Momeni; Gordon K Lee; Dung H Nguyen; Michael T Longaker; Derrick C Wan Journal: Plast Reconstr Surg Date: 2019-04 Impact factor: 4.730
Authors: Abdul Q Sheikh; Courtney Kuesel; Toloo Taghian; Jennifer R Hurley; Wei Huang; Yigang Wang; Robert B Hinton; Daria A Narmoneva Journal: Am J Physiol Cell Physiol Date: 2014-02-26 Impact factor: 4.249
Authors: M Mehrabani; M Najafi; T Kamarul; K Mansouri; M Iranpour; M H Nematollahi; M Ghazi-Khansari; A M Sharifi Journal: Cell Prolif Date: 2015-10 Impact factor: 6.831